| Lincare Inc | |
| 1429 Crossways Blvd, Ste A, Chesapeake, Virginia 23320 | |
| (757) 671-1802 |
| Name | Lincare Inc |
|---|---|
| Organization Name | Lincare Inc |
| Location | 1429 Crossways Blvd, Ste A, Chesapeake, Virginia 23320 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (757) 671-1802 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A technique that measures tiny movements of the eyes may help scientists better understand and perhaps eventually improve assessment of ADHD, according to new research published in Psychological Science, a journal of the Association for Psychological Science.
A new reporter system used to study the bone regeneration potential of human embryonic stem cells has been generated in research led by the University of Minnesota. The new reporter system is the first of its kind for human pluripotent stem cells and is important for identifying certain agents and pathways that mediate early stages of human bone development.
The lack of health insurance prompts people to forego routine physical exams and have a reduced awareness of cardiovascular risk factors and is associated with increased rates of stroke and death, researchers have concluded.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.
› Verified 7 days ago
| NPI Number | 1144257676 |
| Organization Name | LINCARE INC. |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 1429 Crossways Blvd Ste A, Chesapeake, VA 23320 |
| Phone Number | 757-671-1802 |
News Archive
A technique that measures tiny movements of the eyes may help scientists better understand and perhaps eventually improve assessment of ADHD, according to new research published in Psychological Science, a journal of the Association for Psychological Science.
A new reporter system used to study the bone regeneration potential of human embryonic stem cells has been generated in research led by the University of Minnesota. The new reporter system is the first of its kind for human pluripotent stem cells and is important for identifying certain agents and pathways that mediate early stages of human bone development.
The lack of health insurance prompts people to forego routine physical exams and have a reduced awareness of cardiovascular risk factors and is associated with increased rates of stroke and death, researchers have concluded.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.
› Verified 7 days ago
News Archive
A technique that measures tiny movements of the eyes may help scientists better understand and perhaps eventually improve assessment of ADHD, according to new research published in Psychological Science, a journal of the Association for Psychological Science.
A new reporter system used to study the bone regeneration potential of human embryonic stem cells has been generated in research led by the University of Minnesota. The new reporter system is the first of its kind for human pluripotent stem cells and is important for identifying certain agents and pathways that mediate early stages of human bone development.
The lack of health insurance prompts people to forego routine physical exams and have a reduced awareness of cardiovascular risk factors and is associated with increased rates of stroke and death, researchers have concluded.
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today the initiation of a Phase 1 clinical study of Aerucin, the Company's fully human IgG1 monoclonal antibody (mAb) against Pseudomonas aeruginosa bacteria, which is being developed as an adjunctive treatment for acute pneumonia.
› Verified 7 days ago
1st Choice In-homecare Inc Type: Medicare Supplier Location: 1501 Crossways Blvd, Ste A-c, Chesapeake, Virginia 23320 Phone: (757) 496-2030 | |
Abc Health Care Type: Durable Medical Equipment & Medical Supplies Supplier Location: 818 Professional Pl W, Chesapeake, Virginia 23320 Phone: (757) 826-2600 | |
American Cmg Services Inc Type: Prosthetic/Orthotic Supplier Location: 1521 Technology Dr, Chesapeake, Virginia 23320 Phone: (757) 548-5656 | |
Med Emporium #14 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 701 Battlefield Blvd N, Chesapeake, Virginia 23320 Phone: (757) 312-0133 | |
Chesapeake Eye Physicians Type: Medicare Supplier Location: 560 Kempsville Rd, Chesapeake, Virginia 23320 Phone: (757) 410-9500 |